Sonal Adhesives (BSE 526901)₹40.70−1.81%Commodity Chemicals
In the Mar 2026 quarter (standalone), Sonal Adhesives reported sales of ₹34.15 Cr, up 7.7% from Mar 2025, and net profit of ₹0.50 Cr, up 31.6% year on year. For the year to Mar 2026, sales were ₹126 Cr and net profit ₹0.99 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.20 | 27.19 | 25.38 | 26.61 | 24.82 | 27.18 | 26.34 | 31.72 | 28.20 | 34.84 | 28.94 | 34.15 |
| Expenses | 20.60 | 26.82 | 24.94 | 25.74 | 24.05 | 26.55 | 25.96 | 30.94 | 27.46 | 34.46 | 28.47 | 33.56 |
| Operating Profit | 0.72 | 0.57 | 0.61 | 1.01 | 0.90 | 0.80 | 0.51 | 0.96 | 0.93 | 0.58 | 0.67 | 0.78 |
| OPM % | 3.3% | 2.0% | 2.4% | 3.7% | 3.6% | 2.9% | 1.9% | 3.0% | 3.2% | 1.6% | 2.3% | 2.2% |
| Other Income | 0.15 | 0.36 | 0.30 | 0.22 | 0.25 | 0.22 | 0.34 | 0.57 | 0.22 | 0.67 | 0.33 | 0.48 |
| Interest | 0.00 | 0.00 | 0.00 | 0.63 | 0.09 | 0.19 | 0.21 | 0.77 | 0.24 | 0.51 | 0.37 | 0.46 |
| Depreciation | 0.15 | 0.17 | 0.17 | 0.21 | 0.18 | 0.19 | 0.21 | 0.17 | 0.32 | 0.31 | 0.32 | 0.32 |
| Profit before tax | 0.67 | 0.73 | 0.69 | 0.36 | 0.85 | 0.59 | 0.40 | 0.56 | 0.56 | 0.38 | 0.26 | 0.43 |
| Tax % | −3.0% | 5.4% | 74.2% | 27.0% | 24.4% | 26.6% | 24.4% | 31.6% | 21.0% | 33.3% | 44.4% | −15.9% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.69 | 0.69 | 0.17 | 0.26 | 0.63 | 0.43 | 0.29 | 0.38 | 0.44 | 0.26 | 0.14 | 0.50 |
| EPS (Rs) | 1.16 | 1.16 | 0.31 | 0.46 | 1.07 | 0.74 | 0.50 | 0.65 | 0.75 | 0.46 | 0.26 | 0.85 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.92 | 26.95 | 43.87 | 36.92 | 31.92 | 16.96 | 58.85 | 82.77 | 101 | 110 | 126 | 126 |
| Expenses | 28.10 | 31.09 | 47.14 | 38.11 | 34.10 | 18.05 | 58.14 | 80.31 | 98.24 | 107 | 124 | 124 |
| Operating Profit | −3.01 | −4.02 | −3.01 | −1.01 | −2.01 | −1.01 | 0.00 | 3.01 | 3.01 | 3.01 | 3.01 | 2.96 |
| OPM % | −14.0% | −14.0% | −7.0% | −2.6% | −7.0% | −5.0% | 0.8% | 3.7% | 2.9% | 2.8% | 2.3% | 2.4% |
| Other Income | 1.01 | 0.00 | 0.00 | 0.00 | 1.01 | 1.01 | 8.01 | 1.01 | 1.01 | 1.01 | 2.01 | 1.70 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.99 | 0.99 | 1.99 | 1.58 |
| Depreciation | 0.99 | 1.01 | 0.99 | 0.99 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 | 0.99 | 1.27 |
| Profit before tax | −3.99 | −3.99 | −2.99 | −0.99 | −2.99 | −0.99 | 7.98 | 2.99 | 1.99 | 1.99 | 1.99 | 1.63 |
| Tax % | −29.1% | −29.1% | 8.9% | −26.0% | −26.0% | −13.1% | 26.9% | 24.9% | 26.0% | 27.0% | 17.0% | — |
| Exceptional items | 0.20 | 0.00 | 0.00 | −0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | −0.13 | 0.00 |
| Net Profit | −2.99 | −2.99 | −3.99 | −0.99 | −1.99 | −0.99 | 5.99 | 1.99 | 1.99 | 1.99 | 0.99 | 1.34 |
| EPS (Rs) | −4.35 | −5.14 | −6.25 | −1.69 | −3.11 | −1.36 | 9.27 | 3.76 | 3.06 | 2.91 | 2.27 | 2.32 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.98 | 5.98 | 5.98 | 5.98 | 5.98 | 5.97 | 5.98 | 5.98 | 5.98 | 5.98 | 5.98 | 5.98 |
| Reserves | 3.98 | 0.99 | −1.99 | −5.98 | −6.99 | −8.98 | −9.98 | −2.99 | −0.99 | 0.99 | 2.99 | 3.98 |
| Borrowings | 25.03 | 20.02 | 21.03 | 20.03 | 24.03 | 26.02 | 22.02 | 2.01 | 5.01 | 7.01 | 10.02 | 22.01 |
| Other Liabilities | 10.97 | 8.98 | 8.97 | 6.96 | 7.97 | 6.97 | 10.95 | 19.98 | 18.95 | 18.97 | 20.97 | 16.98 |
| Total Liabilities | 45.96 | 35.97 | 32.99 | 27.99 | 31.99 | 29.98 | 28.97 | 24.98 | 28.95 | 32.95 | 39.96 | 48.95 |
| Fixed Assets | 7.01 | 7.02 | 6.01 | 6.01 | 5.01 | 5.01 | 4.01 | 4.01 | 4.01 | 5.01 | 13.02 | 13.02 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 37.95 | 29.95 | 26.98 | 21.98 | 25.98 | 24.97 | 24.96 | 20.97 | 25.94 | 27.94 | 27.94 | 35.93 |
| Inventories | 11.56 | 5.63 | 2.76 | 4.08 | 2.84 | 1.36 | 1.22 | 11.39 | 13.10 | 11.13 | 12.90 | 15.74 |
| Trade receivables | 19.71 | 17.82 | 13.58 | 8.94 | 9.82 | 8.55 | 7.39 | 2.69 | 6.30 | 10.11 | 11.48 | 14.25 |
| Cash & equivalents | 2.45 | 0.85 | 0.81 | 0.72 | 0.63 | 0.62 | 0.68 | 0.04 | 1.00 | 0.43 | 0.00 | 1.28 |
| Total Assets | 45.96 | 35.97 | 32.99 | 27.99 | 31.99 | 29.98 | 28.97 | 24.98 | 28.95 | 32.95 | 39.96 | 48.95 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | −6.01 | 2.01 | — | 1.01 | −4.01 | −1.01 | 4.01 | 19.05 | −1.01 | −1.01 | 7.02 | −7.02 |
| Cash from investing activity | 0.00 | 0.00 | — | 0.00 | 0.00 | 0.00 | 0.00 | 1.01 | −2.01 | −1.01 | −9.04 | −2.01 |
| Cash from financing activity | 7.01 | −4.01 | — | 0.00 | 4.01 | 2.01 | −4.01 | −19.99 | 3.01 | 1.01 | 1.01 | 9.01 |
| Net cash flow | 0.00 | −1.99 | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.99 | 0.00 |
| Capex | 0.19 | 0.17 | 0.32 | 0.42 | 0.05 | 0.52 | 0.02 | 0.29 | 0.00 | 0.00 | 0.00 | 1.79 |
| Free cash flow | −5.99 | 1.99 | — | 0.00 | −3.99 | −1.99 | 3.99 | 17.96 | −0.99 | −0.99 | 6.99 | −8.98 |
| CFO / OP % | −195.0% | −62.0% | — | −20.9% | 391.1% | 62.1% | −426.9% | 4,264.0% | −35.0% | −17.0% | 245.0% | −223.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 166 | 265 | 182 | 75 | 96 | 97 | 158 | 17 | 28 | 37 | 38 | 41 |
| Inventory days | 118 | 83 | 40 | 38 | 32 | 17 | 32 | 80 | 68 | 48 | 50 | 53 |
| Days payable | 78 | 106 | 103 | 60 | 76 | 69 | 132 | 115 | 67 | 66 | 52 | 49 |
| Cash conversion cycle | 206 | 242 | 118 | 53 | 52 | 45 | 58 | −18 | 29 | 18 | 36 | 45 |
| Working capital days | 2 | −48 | −150 | −104 | −130 | −146 | −286 | −23 | −6 | 5 | −7 | 4 |
| ROCE % | 12.1% | −11.9% | −17.0% | −16.0% | −6.0% | −9.0% | −4.0% | 64.1% | 40.0% | 25.0% | 22.1% | 13.1% |
For the Mar 2026 quarter, Sonal Adhesives reported sales of ₹34.15 Cr, up 7.7% year on year and net profit of ₹0.50 Cr, up 31.6% year on year. The operating margin was 2.2%.
Sonal Adhesives' sales for the year to Mar 2026 were ₹126 Cr; over the last twelve months they were ₹126 Cr.
Net profit for the year to Mar 2026 was ₹0.99 Cr, and ₹1.34 Cr over the last twelve months. Earnings per share over the same trailing period were ₹2.32.
Sonal Adhesives reported borrowings of ₹22.01 Cr at Mar 2026, against cash and equivalents of ₹1.28 Cr.
Cash from operations was −₹7.02 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹8.98 Cr.